| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 0.60 | 0.00 (+0.82%) | 0.401 - 5.16 | 296.0 thousand (Below Avg) |
Market data as of 3:59PM 05/21/13. Quotes are delayed by at least 15 min.
| Open | 0.61 |
|---|---|
| Previous Close | 0.60 |
| Day's Range | 0.59 - 0.61 |
| Market Cap | 16.6M |
| Avg Volume (10 Day) | 399.5K |
| Price/Earnings (Trailing 12 Mo.) | -- |
| Earnings Per Share (Trailing 12 Mo.) | -0.68 |
| Dividend Yield | No Dividend |


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Performed well consistently? | Fail |
|---|---|
| Avoids excess debt? | Fail |
| Converting sales to profits? | Fail |
| Shareholder's money handled rationally? | Neutral |
| Increased shareholder value? | Neutral |
| Consistently increased owner earnings? | Fail |
| Sells at 25% discount to intrinsic value? | Fail |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Pays a cash dividend? | Neutral |
|---|---|
| Room to increase dividends? | Fail |
| Increased earnings over time? | Neutral |
| Borrows within reasonable limits? | Pass |
| Stock is undervalued? | Fail |
| Have investors caught on? | Pass |
| Has support of institutional investors? | Fail |
| Has sufficient liquidity? | Pass |
No news headlines available for TZYM
| TZYM | Industry Range | |
|---|---|---|
| Revenue Growth (1yr) | -38.31% | |
| Net Income Growth (1yr) | -- | |
| Total Debt/Equity | 0.00 | |
| LT Debt/Equity | 0.00 | |
| Earnings Yield | -- | |
| Price/Sales | 2.55 |
| Company | Last | Change |
|---|---|---|
| Novogen Ltd | 4.03 | +0.00% |
| Aoxing Pharmaceutical Company Inc | 0.22 | -6.52% |
| China Pharma Holdings Inc | 0.21 | -0.05% |
| Skystar Bio-Pharmaceutical Co | 1.20 | +1.69% |
| Biostar Pharmaceuticals Inc | 0.79 | +5.33% |
Data is delayed by at least 15 min.